..........................................................................................................................

FUNDING
If you visit this page through a search engine....jump to the top page

 

Active Funding

Research Award (PI, R01 AG026478) “Mechanism of Abeta sequestration”, direct cost: $943,000 ($1,463,536 in total), NIA/NIH, 2/1/2007-1/30/2012. [Link]

Carrier Award (PI, K01 AG022455) “Mechanisms of Abeta sequestration in AD”, $630,450, NIA/NIH, 12/1/04-11/31/09. [Link]

Research Award (PI) “Development of BACE1 Inhibitors for Alzheimer's disease”, direct cost to Georgetown: $50,000, Georgetown University and Virginia Tech consortium, 4/1/2007-3/31/2008.

Support from pharmaceutical companies (multiple companies, approximately $150,000/yr).

...............................................................

Pending Funding

Dr. Matsuoka is actively pursuing further external funding. He has multiple pending long-term NIH grants (R01s/R21s) and other foundation grants.

...............................................................

Recently Completed Funding

Academic Teacher Award (Sub-award PI, PI: Maxine Weinstein, K07 AG019165) “Development of AD mouse model with neurodegeneration and cognitive decline”, direct cost: $20,000 ($21,600 in total), National Institute of Aging, 7/1/06-1/31/07.

Intramural Research Grant (PI) “Role of cholesterol efflux and apolipoprotein E in amyloid β clearance”, $20,000, Georgetown University Medical Center, 8/15/04-4/15/05. [Link]

Research Grant (PI, Investigator Initiated Research Grant, IIRG-02-3815), “Peripheral Abeta sequestration as a novel AD therapy”, $239,992, Alzheimer’s Association, 8/1/2002-7/31/2006. [Link. Scroll down to NY state]

Research Grant (PI, 1RO3AG20845-01), “Profile of Aß in response to Aß vaccination”, $84,762, NIA/NIH, 4/1/2002-3/31/2004. [Link]

Biomedical of Translational Research (PI, #2003009) “Development of Aß-binding agents for Aß sequestration therapy”, $98,500, Institute for Studying of Aging, 11/1/2003-10/31/2004. [Link]

..........................................................................................................................